---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-25-001766"
form_type: "8-K"
ticker: "ARTL"
cik: "0001621221"
company_name: "ARTELO BIOSCIENCES, INC."
filed_at: "2025-10-01T23:59:59+00:00"
generated_at: "2026-05-17T05:05:30.590239+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Artelo Biosciences closes $2M public offering of common stock and pre-funded warrants

## Summary
- Gross proceeds ~$2M from 441,210 shares at $4.40/share and 13,335 pre-funded warrants at $4.399/warrant (ex. price $0.001).
- Underwriter R.F. Lafferty has 45-day option to purchase up to additional 68,181 shares/warrants for overallotments.
- Net proceeds will advance preclinical/clinical development, manufacturing, and working capital needs.
- Directors, officers subject to 30-day lock-up; company granted R.F. Lafferty right of first refusal through Dec 31, 2025.

## SEC filing metadata
- accession: 0001640334-25-001766
- form_type: 8-K
- ticker: ARTL
- cik: 0001621221
- company_name: ARTELO BIOSCIENCES, INC.
- filed_at: 2025-10-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1621221/000164033425001766/0001640334-25-001766-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1621221/000164033425001766/artl_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-25-001766
- JSON: https://secwatch.observer/filing/0001640334-25-001766.json
- Plain text: https://secwatch.observer/filing/0001640334-25-001766.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.